GBP5 Expression Predicted Prognosis of Immune Checkpoint Inhibitors in Small Cell Lung Cancer and Correlated with Tumor Immune Microenvironment
Qin Tong,1,* Deyu Li,2,* Yan Yin,1 Lifang Cheng,3 Shuming Ouyang4 1Department of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, People's Republic of China; 2Department of Medical Oncology, Provincial Clinical College, Fujia...
Saved in:
Main Authors: | Tong Q (Author), Li D (Author), Yin Y (Author), Cheng L (Author), Ouyang S (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors
by: Yang Wen, et al.
Published: (2021) -
Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
by: Yuchun Niu, et al.
Published: (2020) -
The role of ERBB4 mutations in the prognosis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors
by: Xilin Hu, et al.
Published: (2021) -
B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis
by: Lin A, et al.
Published: (2022) -
Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment
by: Chunlan Zhang, et al.
Published: (2023)